MMS Holdings Inc. is a clinical research organization that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. MMS has strong industry experience and its scientific approach to drug development makes MMS a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Clients span from top 10 pharma to virtual biotechs, and MMS supports each one with the same standard of excellence. The core service areas include Data Management, Biostatistics, Clinical Programming, Medical and Regulatory Writing, Pharmacovigilance, Clinical Trial Disclosure and Oncology Data Abstraction.
Commitment to quality deliverables sets MMS apart from traditional service providers. MMS is the only CRO to be ISO 9001 certified for all services since inception and MMS maintains detailed quality metrics for every project.